Clinical Trials
2 trialsNCT05174832 2023-09-28
Induction of Cisplatin/Nab-paclitaxel/Pembrolizumab Followed by Olaparib/Pembrolizumab Maintenance in mTNBC Patients
Fudan University
Phase 2 Unknown
NCT02681562 2016-02-15
Olaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer Patients
Istituti Ospitalieri di Cremona
Phase 2 Unknown